Paper · 19084813
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 31
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16556442 | Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model. | Eur J Pharmacol | 2006 | https://conductscience.org/library/papers/16556442 | PubMed |
| 2 | 9395170 | Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart. | J Cardiovasc Electrophysiol | 1997 | https://conductscience.org/library/papers/9395170 | PubMed |
| 3 | 12695296 | Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. | Circulation | 2003 | https://conductscience.org/library/papers/12695296 | PubMed |
| 4 | 7491312 | Basic concepts in cellular cardiac electrophysiology: Part II: Block of ion channels by antiarrhythmic drugs. | Pacing Clin Electrophysiol | 1995 | https://conductscience.org/library/papers/7491312 | PubMed |
| 5 | 7782268 | Acute effects of amiodarone on membrane properties, refractoriness, and conduction in guinea pig papillary muscles. | Heart Vessels | 1995 | https://conductscience.org/library/papers/7782268 | PubMed |
| 6 | 11343415 | Late sodium current is a novel target for amiodarone: studies in failing human myocardium. | J Mol Cell Cardiol | 2001 | https://conductscience.org/library/papers/11343415 | PubMed |
| 7 | 1282594 | Effects of WAY-123,398, a new class III antiarrhythmic agent, on cardiac refractoriness and ventricular fibrillation threshold in anesthetized dogs: a comparison with UK-68798, E-4031, and dl-sotalol. | J Cardiovasc Pharmacol | 1992 | https://conductscience.org/library/papers/1282594 | PubMed |
| 8 | 15302796 | Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. | Circulation | 2004 | https://conductscience.org/library/papers/15302796 | PubMed |
| 9 | 17139288 | Innovative approaches to anti-arrhythmic drug therapy. | Nat Rev Drug Discov | 2006 | https://conductscience.org/library/papers/17139288 | PubMed |
| 10 | 18670368 | Atrial-selective sodium channel blockers: do they exist? | J Cardiovasc Pharmacol | 2008 | https://conductscience.org/library/papers/18670368 | PubMed |
| 11 | 3409504 | Mechanisms of depressed conduction from long-term amiodarone therapy in canine myocardium. | Circulation | 1988 | https://conductscience.org/library/papers/3409504 | PubMed |
| 12 | 15148061 | Transmembrane action potential heterogeneity in the canine isolated arterially perfused right atrium: effect of IKr and IKur/Ito block. | Am J Physiol Heart Circ Physiol | 2004 | https://conductscience.org/library/papers/15148061 | PubMed |
| 13 | 11973411 | Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone. | J Cardiovasc Pharmacol | 2002 | https://conductscience.org/library/papers/11973411 | PubMed |
| 14 | 12649377 | Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation. | J Pharmacol Exp Ther | 2003 | https://conductscience.org/library/papers/12649377 | PubMed |
| 15 | 10466495 | The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart. | J Cardiovasc Electrophysiol | 1999 | https://conductscience.org/library/papers/10466495 | PubMed |
| 16 | 17765636 | A practical guide for clinicians who treat patients with amiodarone: 2007. | Heart Rhythm | 2007 | https://conductscience.org/library/papers/17765636 | PubMed |
| 17 | 15243307 | In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C: electrophysiological, anti-adrenergic, and anti-angiotensin II effects. | J Cardiovasc Pharmacol | 2004 | https://conductscience.org/library/papers/15243307 | PubMed |
| 18 | 14985067 | In vivo electrophysiological effects of a selective slow delayed-rectifier potassium channel blocker in anesthetized dogs: potential insights into class III actions. | Cardiovasc Res | 2004 | https://conductscience.org/library/papers/14985067 | PubMed |
| 19 | 3941203 | Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction. | J Am Coll Cardiol | 1986 | https://conductscience.org/library/papers/3941203 | PubMed |
| 20 | 17785620 | Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. | Circulation | 2007 | https://conductscience.org/library/papers/17785620 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/19084813/references